Statistics from Altmetric.com
For centuries scientific publishing has worked on a bizarre economic model: the real producers of the raw material, the researchers, have received no direct payment for their work. In return for publication they have received exposure, “findability” (thanks to bibliographical databases provided by others), and the “imprimatur” of peer review. Because peer review is an imperfect process,1 exposure and findability are probably the more important benefits. For their part publishers have largely borne the costs of funding peer review systems and of providing the exposure, and in return they have controlled all the rights to their authors’ work and taken all the cash. That has been as true of professional association publishers as it has been of commercial ones: the professional associations can argue that their surpluses have helped to support the work of the associations and their members, but individual researchers have not received any direct monetary reward for their labours. This Journalis now proposing to share some of the cash from commercial reprint sales with its authors. We also hope that we can use the part that we don’t share with them to increase something that may matter more to them—exposure.
This proposal has arisen in part from a closer look at our copyright agreements with authors. Like most publishers we have traditionally asked authors to assign their copyright to us. This has been done so that we can exploit those rights ourselves, and tackle infringements, without having to go back to each author each time. We have also made money out of allowing third parties such as pharmaceutical companies to reprint those articles or translate and distribute them. In practice we have always allowed authors themselves to use their material freely in other publications (such as multiauthor books) and for their own teaching and research purposes without charge. However, recently some authors have become resentful of the fact that publishers take all their rights, often don’t exploit them well, and then insist that they ask permission when authors want to use their own material themselves.
We have therefore decided that we will no longer ask authors to assign their copyrights. Instead we will ask for an exclusive licence. In practice, as several authors have pointed out, this gives us almost the same control as we had before, but we have also undertaken to allow the rights to revert if we haven’t exploited them in the print JNNP or theeJNNP within a year, and in addition authors will no longer have to ask us for permission to use their material for any non-commercial use. Thus if they want to photocopy or download their own article to distribute among their students or place it as a chapter in a multiauthor work (non-commercial product) they can do so without asking; similarly, they can post a copy of their own article on their own or their institution’s website.
We also propose to give our authors 10% of the revenue we make when we sell a reprint order or a translation right worth more than £1000. We will therefore ask authors to nominate someone, or some organisation—the research group or department—to receive any payments. Our reasons for not paying out on smaller orders is because the administration costs would be disproportionately high, and our reasons for not giving more than a small percentage is because we need the revenue to help fund publication of theJournal. Although we hope that sharing our reprint revenue might help pay something back to the scientific community which we serve and on which we depend, we think that we can best keep our contract with authors by working hard to increase their exposure.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.